Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of GBP 160.50 billion. The enterprise value is 174.43 billion.

Market Cap	160.50B
Enterprise Value	174.43B

Important Dates

The next estimated earnings date is Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.91%
Shares Change (QoQ)	-0.93%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.91B

Valuation Ratios

The trailing PE ratio is 12.22.

PE Ratio	12.22
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.89, with an EV/FCF ratio of 15.84.

EV / Earnings	13.28
EV / Sales	4.62
EV / EBITDA	10.89
EV / EBIT	12.63
EV / FCF	15.84

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.74.

Current Ratio	1.11
Quick Ratio	0.78
Debt / Equity	0.74
Debt / EBITDA	1.51
Debt / FCF	2.18
Interest Coverage	19.33

Financial Efficiency

Return on equity (ROE) is 28.79% and return on invested capital (ROIC) is 16.47%.

Return on Equity (ROE)	28.79%
Return on Assets (ROA)	10.59%
Return on Capital (ROIC)	16.47%
Revenue Per Employee	489,899
Profits Per Employee	172,681
Employee Count	76,057
Asset Turnover	0.46
Inventory Turnover	2.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.98% in the last 52 weeks. The beta is 0.51, so Novartis AG's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-4.98%
50-Day Moving Average	90.50
200-Day Moving Average	94.20
Relative Strength Index (RSI)	48.07
Average Volume (20 Days)	642,956

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of GBP 37.26 billion and earned 13.13 billion in profits. Earnings per share was 6.40.

Revenue	37.26B
Gross Profit	28.25B
Operating Income	13.67B
Pretax Income	9.50B
Net Income	13.13B
EBITDA	15.66B
EBIT	13.67B
Earnings Per Share (EPS)	6.40

Full Income Statement

Balance Sheet

The company has 10.33 billion in cash and 23.99 billion in debt, giving a net cash position of -13.66 billion.

Cash & Cash Equivalents	10.33B
Total Debt	23.99B
Net Cash	-13.66B
Net Cash Per Share	n/a
Equity (Book Value)	32.41B
Book Value Per Share	16.17
Working Capital	2.34B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.92 billion and capital expenditures -905.77 million, giving a free cash flow of 11.01 billion.

Operating Cash Flow	11.92B
Capital Expenditures	-905.77M
Free Cash Flow	11.01B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.83%, with operating and profit margins of 36.69% and 35.25%.

Gross Margin	75.83%
Operating Margin	36.69%
Pretax Margin	25.49%
Profit Margin	35.25%
EBITDA Margin	42.02%
EBIT Margin	36.69%
FCF Margin	29.55%

Dividends & Yields

Novartis AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	152.75%
Years of Dividend Growth	n/a
Payout Ratio	43.31%
Buyback Yield	2.91%
Shareholder Yield	2.91%
Earnings Yield	8.18%
FCF Yield	6.86%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.85.

Altman Z-Score	3.85
Piotroski F-Score	n/a